News Search

Category: Schools

Penn Spinout Gemma Therapeutics Raises $34 million to Develop Gene Therapies for Rare Diseases  

Gemma Bio raised $34 million in a seed round led by Double Point Ventures, Bioluminescence Ventures and Earlybird Venture Capital.

Stentix Awarded 2025 Y-Prize 

Stentix won the 2025 Y-Prize competition after presenting their business plan for a bile duct stent that can be adjusted noninvasively to help patients maintain bile flow without further surgical inte

Michael Kahana Featured in NY Post for Memory Research  

Michael Kahana was recently featured in the New York Post for his cutting-edge research in memory recall.

Penn Engineering’s Shu Yang to Co-Design Artificial Reef Structures that Help Harness Wave Energy  

Dr. Yang’s focus is developing low-cost and recycled carbonated materials that are safe for, and tolerant of, the marine environment.

Jay Z’s Shawn Carter Foundation in Collaboration with Coalition for Equity and Opportunity at Penn’s Wharton School, Launch ‘Champions for Financial Legacy’ Program for HBCUs 

This partnership focuses on transforming Dr. Weigelt's community program, "Bridges to Wealth," into a broader initiative called "Champions for Financial Legacy."

Mitchell Lab Discovers Siloxane-Enhanced Nanoparticles and Refines LNPs to Advance mRNA Medicine   

A group of researchers at Penn Engineering led by Michael Mitchell, PhD, Associate Professor in Bioengineering, have developed a method to direct lipid nanoparticles (LNPs) to target specific tissues.

Franklin Biolabs Names its First CEO

Franklin Biolabs, a Penn spinout founded by James Wilson, MD, PhD, Rose H. Weiss Professor in Penn Medicine, has named Vatsala Naageshwaran as its first chief executive officer. 

Ocuphire Pharma Announces Acquisition of Opus Genetics, a Penn startup based on technology developed by Dr. Jean Bennett and colleagues   

The merger between Opus and Ocuphire creates a transformative biotech company, renamed Opus Genetics, Inc, which is committed to the development of gene therapies for the treatment of IRDs.

EpiVario Secures Key Patents for Innovative Addiction Treatment  

EpiVario, Inc., a Penn spinout co-founded by Shelley Berger, PhD, the Daniel S. Och University Professor at Penn Medicine, announced the issuance to Penn of US Patent No. 12,077,527.

Penn spinout REGENXBIO Presents Positive Data from Phase II Study for Wet AMD Treatment   

Penn spinout REGENXBIO, co-founded by James Wilson, MD, PhD, Rose H. Weiss Professor in Penn Medicine, announced positive results from a phase II study for its treatment ABBV-RGX-314.

Filter